News & Events

• May 1, 2019 - May 3, 2019
  

  2019 Annual International Neonatal Scientific Workshop

  Dear Colleague, You are cordially invited to participate in the 2019 Annual International Neonatal Consortium Workshop at the Hyatt Regency Bethesda on May 1st – 3rd, 2019. This workshop will build on the progress of INC Work Groups to improve the conduct of trials to evaluate the safety and effectiveness of therapies for neonates. Meetings...
• March 18, 2019
  

  C-Path President and CEO, Board Director Selected to Serve on Esteemed National Academies of Sciences, Engineering and Medicine Committee

  C-Path President and CEO Martha Brumfield, PhD, and C-Path board director Alastair J. Wood, MD, FRCP, have both been selected to the serve on the National Academy Consensus Committee examining Mutual Recognition Agreements in the Regulation of Medicines under The National Academies of Sciences, Engineering and Medicine. Dr. Wood will serve as chair. An ad...
• March 14, 2019
  

  C-Path, FNIH Announce Clinical Development User’s Guide for Kidney Safety Biomarkers

      TUCSON, Ariz., March 14, 2019 — The Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PSTC) today announced availability of the User’s Guide: Kidney Safety Composite Measure Biomarker for Use in Clinical Development. Authored by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Kidney Safety Biomarker Project Team and PSTC’s...
• February 27, 2019
  

  C-Path and FARA Launch Friedreich’s Ataxia Integrated Clinical Database to Advance the Development of Treatments for FA

  TUCSON, Ariz. and DOWNINGTOWN, Penn., February 27, 2019 — Critical Path Institute’s (C-Path) Data Collaboration Center (DCC) and the Friedreich’s Ataxia Research Alliance (FARA) today announced the launch of the Friedreich’s Ataxia Integrated Clinical Database (FAICD). The new platform will enable collaborative research and data sharing to support the understanding of natural history, potential biomarkers...
• January 17, 2019
  

  Critical Path Institute Celebrates Expanded Operations with Opening of European Headquarters

    C-Path in the EU will work to accelerate the development of new therapies through innovative methodologies for endorsement by regulators of pharmaceutical products TUCSON, Ariz., January 17, 2019 — Critical Path Institute (C-Path) is excited to announce the launch of Critical Path Institute, Ltd. (C-Path, Ltd.) in Ireland, a fully-owned subsidiary that will enable C-Path to...